Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

675
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
675
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

744
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
744
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

708
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
708
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same author

Misrepresentation of pneumonia data.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Balance Versus Bias: Correcting Misinformation About the 2025 ATS Community-Acquired Pneumonia Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Redefining the role of indwelling pleural catheters at thoracoscopy.

The Lancet. Respiratory medicine·2026
Same author

Recent advances in the diagnosis and management of community-acquired pneumonia.

Current opinion in pulmonary medicine·2026
Same author

Formulary optimization to reduce the carbon footprint of inhalers in a tertiary hospital.

The International journal of pharmacy practice·2025

Related Experiment Video

Updated: Jan 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Invasive Pneumococcal and Meningococcal Disease.

Deirdre Fitzgerald1, Grant W Waterer2

  • 1Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Verdun Street, Nedlands, Perth 6009, Australia.

Infectious Disease Clinics of North America
|November 1, 2019
PubMed
Summary

Invasive pneumococcal disease (IPD) and invasive meningococcal disease (IMD) require effective prevention and treatment strategies. While vaccines reduced IPD, cases are increasing, and antibiotic resistance is a growing concern for IMD.

Keywords:
EpidemiologyInvasiveMeningococcalPneumococcalTreatment

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.6K
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

13.0K

Related Experiment Videos

Last Updated: Jan 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.6K
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

13.0K

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Vaccinology

Background:

  • Invasive pneumococcal disease (IPD) and invasive meningococcal disease (IMD) remain significant global health threats.
  • Effective conjugate vaccines have historically reduced IPD incidence, but recent trends indicate a resurgence.
  • Rising antibiotic resistance in Neisseria meningitidis poses a major challenge for IMD treatment.

Purpose of the Study:

  • To review the current epidemiology, prevention strategies, and treatment guidelines for IPD and IMD.
  • To highlight emerging trends and challenges in managing these invasive bacterial infections.
  • To discuss the role of vaccines and antibiotic therapy in controlling IPD and IMD.

Main Methods:

  • Comprehensive literature review of epidemiological data, clinical studies, and treatment guidelines.
  • Analysis of vaccine efficacy and impact on disease incidence.
  • Evaluation of current and emerging antibiotic treatment regimens and resistance patterns.

Main Results:

  • IPD incidence declined post-vaccine introduction but is now increasing.
  • Effective IPD treatment involves beta-lactam and macrolide combinations, with specific considerations for meningitis.
  • Steroids are crucial for pneumococcal meningitis but not pneumonia, except in refractory shock.
  • Cardiovascular complications of IPD are a growing concern.
  • Increasing antibiotic resistance is a critical issue for IMD management.

Conclusions:

  • Continued surveillance and updated vaccination strategies are essential for controlling IPD.
  • Addressing rising antibiotic resistance is paramount for effective IMD prevention and treatment.
  • Integrated approaches combining vaccination, prompt diagnosis, and appropriate antimicrobial therapy are vital for reducing the burden of IPD and IMD.